Search Results - "Kondratchik, K. L."

Age-related characteristics of the efficacy of different glucocorticosteroids in the therapy of acute lymphoblastic leukemia by Karachunsky, A I, Rumyantseva, Yu V, Lagoiko, S N, Bührer, C, Tallen, G, Aleinikova, O V, Bydanov, O I, Korepanova, N V, Baidun, L V, Nasedkina, T V, Stackelberg, A Von, Novichkova, G A, Maschan, A A, Litvinov, D V, Ponomareva, N I, Kondratchik, K L, Mansurova, E G, Fechina, L G, Streneva, O V, Yudina, N B, Sharapova, G R, Shamardina, A V, Gerbek, I E, Shapochnik, A P, Rumyantsev, A G, Henze, G

“…To determine predictors for decision-making on a differential approach to choosing glucocorticosteroids (GCS) for children and adolescents with acute…”
Get full text

Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia by Valiev, T. T., Kumirova, E. V., Rozinov, V. M., Panferova, T. R., Khvorostov, I. N., Kondratchik, K. L., Fuks, O. Yu, Kerimov, P. A., Matinyan, N. V., Belyaeva, A. V., Efremenkov, A. M., Bystrova, A. A., Kurkin, A. P., Gorev, V. V.

“…L-asparaginase is one of the most effective drugs in pediatric and adult acute lymphoblastic leukemia treatment. But drug side effects are an important…”
Get full text

Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition by Nemirovchenko, V. S., Shervashidze, M. A., Valiev, T. T., Kondratchik, K. L.

“…Background . Currently, overall survival rate for pediatric patients with acute myeloid leukemia (AML) do not exceed 70 %. The intensity of modern AML…”
Get full text

Epilepsy in children with lymphoproliferative syndrome by Schederkina, I. O., Tiganova, O. A., Koltunov, I. E., Natrusova, N. V., Kondratchik, K. L.

“…There are considerable variations in the reported incidence of early and late epilepsy in children with lymphoproliferative diseases. The etiology of seizures…”
Get full text

Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia by Rumiantseva, Iu V, Karachunskiĭ, A I, Aleĭnikova, O V, Fechina, L G, Shamardina, A V, Litvinov, D V, Ponomareva, N I, Boĭchenko, E G, Dudkin, S A, Streneva, O V, Kondratchik, K L, Mansurova, E G, Minkina, L M, Lapotentova, E S, Iniushkina, E V, Iudina, N B, Pavlova, G P, Zhukovskaia, E V, Khlebnikova, O P, Lagoĭko, S N, Basharova, E V, Denisov, R E, Zlobina, V D, Banshchikova, E S, Aslanian, K S, Kondakova, E V, Tselousova, E V, Miakova, N V, Turobova, T V, Ryskal', O V, Chipsanova, N F, Varfolomeeva, S R, Rumiantsev, A G

“…To evaluate the efficiency of the original ALL-MB-2002 protocol within the multicenter study of treatment of acute lymphoblastic leukemia (ALL) in children. A…”
Get full text

Comparative analysis of three various chemotherapy protocols for acute lymphoblastic leukemia BFM-90m, MB-91 and PECO-92 in Moscow and St.-Petersburg by E. G. Boichenko, E. M. Petrova, M. B. Ivanovskaya, I. A. Garbusova, M. B. Belogurova, G. G. Radulesku, Yu. V. Roumiantseva, D. V. Litvinov, S. N. Lagoiko, K. L. Kondratchik, N. I. Ponomareva, N. R. Tukalova, A. I. Karachunsky

“…Comparative retrospective analysis of treatment results of three different chemotherapy protocols - ALL BFM 90m, ALL MB 91 and PECO 92 — in primary ALL…”
Get full text

Comparative analysis of therapy results in children with acute lymphoblastic leukemia receiving ALL-MB-2002 and COALL-St.Petersburg-92 protocols by E. G. Boychenko, J. V. Rumyantseva, N. I. Ponomareva, M. S. Livschiz, I. A. Garbusova, M. B. Belogurova, L. I. Schaz, D. V. Litvinov, S. N. Lagoiko, K. L. Kondratchik, N. R. Tukalova, A. I. Karachunsky

“…In present article comparative efficacy analysis of two conceptually various acute lymphoblastic leukemia (ALL) chemotherapy programs from 18. 04. 2002 till…”
Get full text

Long-term results of Berlin-Frankfurt-Muenster based therapy for childhood and adolescents’ lymphoblastic lymphoma by S. S. Kulikova, S. V. Semochkin, D. V. Litvinov, E. V. Inuschkina, N. V. Myakova, K. L. Kondratchik, L. V. Baidun, D. M. Konovalov, D. A. Peregudov, L. N. Schelichova, E. V. Samochatova

“…Lymphoblastic lymphoma (LBL) is one of predominant childhood non-Hodgkin’s lymphoma (NHL) subtypes and consists 25—30 %.   The study purpose was to investigate…”
Get full text

Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol by M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky

“…The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG)…”
Get full text

Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols by J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev

“…Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих терапию по протоколу…”
Get full text

Translocation t(1;11)(p32;q23) with MLL-EPS15 fusion gene formation in acute leukemias: a review and 6 new case reports. Approaches to minimal residual disease monitoring by G. A. Tsaur, A. M. Popov, O. M. Plekhanova, A. M. Kustanovich, O. V. Aleynikova, T. L. Gindina, A. S. Demina, A. Ye. Druy, S. Yu. Kovalev, K. L. Kondratchik, A. V. Misyurin, N. V. Myakova, T. O. Riger, L. I. Savelyev, O. I. Sokova, O. V. Streneva, M. V. Suchkova, Yu. P. Finashutina, Ye. V. Fleyshman, Ye. V. Shorikov, R. I. Yutskevich, C. Meyer, R. Marschalek, L. G. Fechina

“…We performed clinical and laboratory characterization of patients with rare translocation t(1;11)(p32;q23) leading to MLL-EPS15 fusion gene formation. Study…”
Get full text

Translocation t(1;11)(p32;q23) with MLL-EPS15 fusion gene formation in acute leukemias: a review and 6 new case reports. Approaches to minimal residual disease monitoring by G. A. Tsaur, A. M. Popov, O. M. Plekhanova, A. M. Kustanovich, O. V. Aleynikova, T. L. Gindina, A. S. Demina, A. Ye. Druy, S. Yu. Kovalev, K. L. Kondratchik, A. V. Misyurin, N. V. Myakova, T. O. Riger, L. I. Savelyev, O. I. Sokova, O. V. Streneva, M. V. Suchkova, Yu. P. Finashutina, Ye. V. Fleyshman, Ye. V. Shorikov, R. I. Yutskevich, C. Meyer, R. Marschalek, L. G. Fechina

“…We performed clinical and laboratory characterization of patients with rare translocation t(1;11)(p32;q23) leading to MLL-EPS15 fusion gene formation. Study…”
Get full text

Glucocorticoid interaction with bone marrow lymphoblast receptors in acute leukemia by Dukhanin, A. S., Erina, T. A., Bulaeva, N. N., Chernov, V. M., Stankevich, L. I., Kondratchik, K. L., Lobanovskii, A. L.

Get full text

Clinico-hematologic and prognostic characteristics of immunocytologic subvariants of lymphoblastic leukemia in children by Kondratchik, K L

Get more information

Cephalosporins in the treatment of children with oncohematologic diseases by Nepokul'chitskaia, N V, Timakov, A M, Kondratchik, K L, Makhortykh, T Zh, Tarasova, I S, Erina, T A

“…Clinical efficacy of 3rd generation cephalosporins i.e. oral cefpodoxime and parenteral ceftriaxone was studied in the treatment of children with…”
Get more information

Duration of the first remission and survival rate of children with acute lymphoblastic leukemia after use of thymus preparations in the remission period by Kisliak, N S, Chernov, V M, Kondratchik, K L, Pronina, L Kh, Stolov, A M

Get more information

Retrospective evaluation of blood immunologic parameters in the course of remission of acute lymphoblastic leukemia in children by Kisliak, N S, Lenskaia, R V, Shvedova, E Iu, Kolenkova, G V, Kondratchik, K L, Finogenova, N A, Mamedova, E A, Akk, A M, Lutskaia, Ia Ia, Dolgina, E N, Afanas'eva, A A, Pronina, L Kh

“…The authors investigated cellular and humoral immunity in 53 children over 3 years of age suffering from acute lymphoblastic leukemia. The children had…”
Get more information

Ultrastructural picture and nucleolus organizer activity of leukemic cells in children with acute lymphoblastic leukemia of the "general" type by Ikonnikova, O A, Lenskaia, R V, Kondratchik, K L, Chernov, V M

Get more information

Monoclonal immunophenotyping of acute lymphoblastic leukemia cells in children using rapid immune alkaline phosphatase by Kolenkova, G V, Luk'ianova, A G, Lenskaia, R V, Kisliak, N S, Kenny, M, Makhartykh, T Zh, Kondratchik, K L, Chernov, V M

“…Monoclonal immunophenotyping of leukemia cells of the bone marrow was carried out by the method of rapid immune alkaline phosphatase (RIAP) in 30 patients with…”
Get more information

Interaction of glucocorticoids with bone marrow lymphoblast receptors in acute leukemia by Dukhanin, A S, Erina, T A, Bulaeva, N N, Chernov, V M, Stankevich, L I, Kondratchik, K L, Lobanovskiĭ, A L

“…Two types of receptor systems for glucocorticoids: membranous and intracellular have been found on lymphoblasts of children with acute lymphoblastic leukemia…”
Get more information